Skin under tension isn’t passive: the Piezo1 protein detects stretch and triggers the changes needed for tissue growth. Credit: Nature Communications, Yingchao Xue, Luis A. Garza
A stretch-sensing protein called Piezo1 (a membrane ion channel that lets calcium into skin cells when they are pulled) appears to coordinate the immune and metabolic programs that let skin grow under tension, Johns Hopkins researchers report in Nature Communications. In mice, chemically activating Piezo1 during tissue expansion significantly increased skin surface area and epidermal thickness compared with untreated controls (AUC P=0.005; thickness P<0.0001), while deleting Piezo1 (a mechanosensitive ion channel protein) in skin blunted these measures. The findings suggest a potential pharmacologic alternative to surgical expanders for generating graftable skin, pending human data.
The research builds on a decade of Piezo1 research, first identified in 2010 as a mechanosensitive ion channel that gates calcium influx under force. In skin, early studies linked it to touch sensation and epithelial homeostasis, with a 2021 eLife paper showing that epidermal Piezo1 slowed wound closure when enhanced and sped closure when deleted. A 2022 study found Piezo1’s shear stress response depends on extracellular matrix proteins like fibronectin, collagen and laminin, which regulate channel sensitivity.
Piezo1’s dual role in healing and scarring
Wound healing research overlaps heavily. A 2024 review summarizes Piezo1 roles across platelets (for clotting), neutrophils and macrophages (inflammation control), endothelial cells (angiogenesis), keratinocytes (re-epithelialization) and fibroblasts (remodeling), noting it prevents excessive scarring by fine-tuning inflammation. In fibrosis, a 2021 Cell Death & Disease paper showed that mechanical stretch promotes hypertrophic scar formation via Piezo1, linking stiff substrates to metabolic shifts that promote TGF-beta signaling—a pathway also upregulated in the Hopkins tension model for immune and growth regulation.
Expanding Piezo1’s reach across tissues
Beyond wounds, Piezo1 influences regeneration elsewhere. A 2024 Theranostics review covered its effects on mesenchymal stem cells, driving differentiation under force in bone, muscle and vascular tissues—patterns mirrored in skin expansion. The Hopkins paper reports heightened CXCL/CCL/TNF/TGF-β signaling during expansion, supporting the immune and growth-control framework.
The Hopkins paper stands out by focusing on non-injury tension growth, using spatial transcriptomics to map systemic responses like immune infiltration and glucose shifts, with Piezo1 as the trigger. It differentiates from wound models (often fibrotic) by emphasizing regenerative expansion. Gaps include human relevance, off-target effects of the chemical activator and full circuit mapping, but it advances toward pharmacologic alternatives to invasive tissue expanders.
